BMCRX
Price
$25.28
Change
-$0.57 (-2.21%)
Updated
Feb 21 closing price
Net Assets
1.38B
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

BMCRX vs GFACX

Header iconBMCRX vs GFACX Comparison
Open Charts BMCRX vs GFACXBanner chart's image
BlackRock Advantage Large Cap Gr R
Price$25.28
Change-$0.57 (-2.21%)
VolumeN/A
Net Assets1.38B
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
BMCRX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMCRX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMCRX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. BMCRX (1.38B). BMCRX (0.00) and GFACX (0.00) have matching dividends . BMCRX was incepted earlier than GFACX: BMCRX (15 years) vs GFACX (24 years). BMCRX is a more actively managed with annual turnover of: 130.00 vs. GFACX (31.00). BMCRX has a lower initial minimum investment than GFACX: BMCRX (100) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. BMCRX (1.00). BMCRX return over 5 years is better than : 36.04 vs. GFACX (32.83).
BMCRXGFACXBMCRX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years24 years-
Gain YTD1.4042.98047%
Front LoadN/AN/A-
Min. Initial Investment10025040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.38B304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year1.0010.1510%
Returns for 3 years24.5817.69139%
Returns for 5 years36.0432.83110%
Returns for 10 years93.6755.63168%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding